New antibody combo takes on Hard-to-Treat cancers
Disease control
Recruiting now
This early-stage trial tests an experimental drug called ADU-1805, alone or combined with the immunotherapy Keytruda, in adults with advanced solid tumors that have stopped responding to standard treatments. The main goals are to check safety and find the right dose. About 130 pa…
Phase: PHASE1 • Sponsor: Sairopa B.V. • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC